![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 17167 |
FusionGeneSummary for IGF2R_SLC22A3 |
![]() |
Fusion gene information | Fusion gene name: IGF2R_SLC22A3 | Fusion gene ID: 17167 | Hgene | Tgene | Gene symbol | IGF2R | SLC22A3 | Gene ID | 3482 | 6581 |
Gene name | insulin like growth factor 2 receptor | solute carrier family 22 member 3 | |
Synonyms | CD222|CI-M6PR|CIMPR|M6P-R|M6P/IGF2R|MPR 300|MPR1|MPR300|MPRI | EMT|EMTH|OCT3 | |
Cytomap | 6q25.3 | 6q25.3 | |
Type of gene | protein-coding | protein-coding | |
Description | cation-independent mannose-6-phosphate receptor300 kDa mannose 6-phosphate receptorCI Man-6-P receptorIGF-II receptorM6P/IGF2 receptorinsulin-like growth factor II receptor | solute carrier family 22 member 3EMT organic cation transporter 3extraneuronal monoamine transporterorganic cation transporter 3solute carrier family 22 (extraneuronal monoamine transporter), member 3solute carrier family 22 (organic cation transport | |
Modification date | 20180527 | 20180522 | |
UniProtAcc | P11717 | O75751 | |
Ensembl transtripts involved in fusion gene | ENST00000356956, ENST00000475584, | ENST00000275300, ENST00000392145, | |
Fusion gene scores | * DoF score | 7 X 6 X 6=252 | 2 X 2 X 2=8 |
# samples | 6 | 3 | |
** MAII score | log2(6/252*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/8*10)=1.90689059560852 | |
Context | PubMed: IGF2R [Title/Abstract] AND SLC22A3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SLC22A3 | GO:0015695 | organic cation transport | 10966924|16024787 |
Tgene | SLC22A3 | GO:0015697 | quaternary ammonium group transport | 10966924 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-BH-A0BL-01A | IGF2R | chr6 | 160431817 | + | SLC22A3 | chr6 | 160819011 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000356956 | ENST00000275300 | IGF2R | chr6 | 160431817 | + | SLC22A3 | chr6 | 160819011 | + |
In-frame | ENST00000356956 | ENST00000392145 | IGF2R | chr6 | 160431817 | + | SLC22A3 | chr6 | 160819011 | + |
intron-3CDS | ENST00000475584 | ENST00000275300 | IGF2R | chr6 | 160431817 | + | SLC22A3 | chr6 | 160819011 | + |
intron-3CDS | ENST00000475584 | ENST00000392145 | IGF2R | chr6 | 160431817 | + | SLC22A3 | chr6 | 160819011 | + |
Top |
FusionProtFeatures for IGF2R_SLC22A3 |
![]() |
Hgene | Tgene |
IGF2R | SLC22A3 |
Transport of phosphorylated lysosomal enzymes from theGolgi complex and the cell surface to lysosomes. Lysosomal enzymesbearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resultingreceptor-ligand complex is transported to an acidic prelyosomalcompartment where the low pH mediates the dissociation of thecomplex. This receptor also binds IGF2. Acts as a positiveregulator of T-cell coactivation, by binding DPP4.{ECO:0000269|PubMed:10900005}. | Mediates potential-dependent transport of a variety oforganic cations. May play a significant role in the disposition ofcationic neurotoxins and neurotransmitters in the brain.{ECO:0000269|PubMed:10196521, ECO:0000269|PubMed:10966924}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >SLC22A3 | chr6:160431817 | chr6:160819011 | ENST00000275300 | + | 0 | 11 | 182_202 | 143 | 557 | Transmembrane | Helical |
Tgene | >SLC22A3 | chr6:160431817 | chr6:160819011 | ENST00000275300 | + | 0 | 11 | 241_261 | 143 | 557 | Transmembrane | Helical |
Tgene | >SLC22A3 | chr6:160431817 | chr6:160819011 | ENST00000275300 | + | 0 | 11 | 269_289 | 143 | 557 | Transmembrane | Helical |
Tgene | >SLC22A3 | chr6:160431817 | chr6:160819011 | ENST00000275300 | + | 0 | 11 | 381_401 | 143 | 557 | Transmembrane | Helical |
Tgene | >SLC22A3 | chr6:160431817 | chr6:160819011 | ENST00000275300 | + | 0 | 11 | 468_488 | 143 | 557 | Transmembrane | Helical |
Tgene | >SLC22A3 | chr6:160431817 | chr6:160819011 | ENST00000275300 | + | 0 | 11 | 498_518 | 143 | 557 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 1898_1944 | 171 | 2492 | Domain | Fibronectin type-II |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 1100_1243 | 171 | 2492 | Repeat | Note=8 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 1244_1384 | 171 | 2492 | Repeat | Note=9 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 1385_1532 | 171 | 2492 | Repeat | Note=10 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 1533_1666 | 171 | 2492 | Repeat | Note=11 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 1667_1820 | 171 | 2492 | Repeat | Note=12 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 1821_2008 | 171 | 2492 | Repeat | Note=13 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 190_344 | 171 | 2492 | Repeat | Note=2 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 2009_2137 | 171 | 2492 | Repeat | Note=14 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 2165_2289 | 171 | 2492 | Repeat | Note=15 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 345_489 | 171 | 2492 | Repeat | Note=3 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 40_189 | 171 | 2492 | Repeat | Note=1 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 490_643 | 171 | 2492 | Repeat | Note=4 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 644_783 | 171 | 2492 | Repeat | Note=5 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 784_950 | 171 | 2492 | Repeat | Note=6 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 951_1099 | 171 | 2492 | Repeat | Note=7 |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 2328_2491 | 171 | 2492 | Topological domain | Cytoplasmic |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 41_2304 | 171 | 2492 | Topological domain | Lumenal |
Hgene | >IGF2R | chr6:160431817 | chr6:160819011 | ENST00000356956 | + | 4 | 48 | 2305_2327 | 171 | 2492 | Transmembrane | Helical |
Tgene | SLC22A3 | chr6:160431817 | chr6:160819011 | ENST00000275300 | + | 0 | 11 | 21_41 | 143 | 557 | Transmembrane | Helical |
Top |
FusionGeneSequence for IGF2R_SLC22A3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_IGF2R_ENST00000356956_chr6_160431817_+_SLC22A3_ENST00000275300_chr6_160819011_+_585aa MGAAAGRSPHLGPAPARRPQRSLLLLQLLLLVAAPGSTQAQAAPFPELCSYTWEAVDTKNNVLYKINICGSVDIVQCGPSSAVCMHDLKT RTYHSVGDSVLRSATRSLLEFNTTVSCDQQGTNHRVQSSIAFLCGKTLGTPEFVTATECVHYFEWRTTAACKKDIFKANKEFDLVCVNAW MLDLTQAILNLGFLTGAFTLGYAADRYGRIVIYLLSCLGVGVTGVVVAFAPNFPVFVIFRFLQGVFGKGTWMTCYVIVTEIVGSKQRRIV GIVIQMFFTLGIIILPGIAYFIPNWQGIQLAITLPSFLFLLYYWVVPESPRWLITRKKGDKALQILRRIAKCNGKYLSSNYSEITVTDEE VSNPSFLDLVRTPQMRKCTLILMFAWFTSAVVYQGLVMRLGIIGGNLYIDFFISGVVELPGALLILLTIERLGRRLPFAASNIVAGVACL VTAFLPEGIAWLRTTVATLGRLGITMAFEIVYLVNSELYPTTLRNFGVSLCSGLCDFGGIIAPFLLFRLAAVWLELPLIIFGILASICGG >In-frame_IGF2R_ENST00000356956_chr6_160431817_+_SLC22A3_ENST00000392145_chr6_160819011_+_586aa MGAAAGRSPHLGPAPARRPQRSLLLLQLLLLVAAPGSTQAQAAPFPELCSYTWEAVDTKNNVLYKINICGSVDIVQCGPSSAVCMHDLKT RTYHSVGDSVLRSATRSLLEFNTTVSCDQQGTNHRVQSSIAFLCGKTLGTPEFVTATECVHYFEWRTTAACKKDIFKANKEFDLVCVNAW MLDLTQAILNLGFLTGAFTLGYAADRYGRIVIYLLSCLGVGVTGVVVAFAPNFPVFVIFRFLQGVFGKGTWMTCYVIVTEIVGSKQRRIV GIVIQMFFTLGIIILPGIAYFIPNWQGIQLAITLPSFLFLLYYWVVPESPRWLITRKKGDKALQILRRIAKCNGKYLSSNYSEITVTDEE VSNPSFLDLVRTPQMRKCTLILMFAWFTSAVVYQGLVMRLGIIGGNLYIDFFISGVVELPGALLILLTIERLGRRLPFAASNIVAGVACL VTAFLPEAGIAWLRTTVATLGRLGITMAFEIVYLVNSELYPTTLRNFGVSLCSGLCDFGGIIAPFLLFRLAAVWLELPLIIFGILASICG |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_IGF2R_ENST00000356956_chr6_160431817_+_SLC22A3_ENST00000275300_chr6_160819011_+_1755nt ATGGGGGCCGCCGCCGGCCGGAGCCCCCACCTGGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTG CTCGTCGCTGCCCCGGGGTCCACGCAGGCCCAGGCCGCCCCGTTCCCCGAGCTGTGCAGTTATACATGGGAAGCTGTTGATACCAAAAAT AATGTACTTTATAAAATCAACATCTGTGGAAGTGTGGATATTGTCCAGTGCGGGCCATCAAGTGCTGTTTGTATGCACGACTTGAAGACA CGCACTTATCATTCAGTGGGTGACTCTGTTTTGAGAAGTGCAACCAGATCTCTCCTGGAATTCAACACAACAGTGAGCTGTGACCAGCAA GGCACAAATCACAGAGTCCAGAGCAGCATTGCCTTCCTGTGTGGGAAAACCCTGGGAACTCCTGAATTTGTAACTGCAACAGAATGTGTG CACTACTTTGAGTGGAGGACCACTGCAGCCTGCAAGAAAGACATATTTAAAGCAAATAAGGAGTTTGACCTTGTCTGTGTCAATGCGTGG ATGCTGGACCTCACCCAAGCCATCCTGAACCTCGGCTTCCTGACTGGAGCATTCACCTTAGGCTATGCAGCAGACAGGTATGGCAGGATC GTCATTTACTTGCTATCCTGCCTTGGTGTTGGCGTCACTGGGGTTGTGGTGGCCTTTGCACCAAACTTCCCTGTGTTTGTGATCTTCCGC TTCCTGCAAGGTGTATTTGGAAAGGGGACGTGGATGACTTGCTACGTGATTGTGACAGAAATAGTAGGTTCGAAACAAAGGAGGATTGTG GGAATCGTGATTCAAATGTTCTTTACCCTTGGAATCATAATTCTCCCTGGAATTGCCTACTTCATCCCCAACTGGCAAGGAATCCAGTTA GCCATCACGCTGCCCAGCTTTCTCTTCCTCCTTTATTACTGGGTGGTCCCTGAGTCTCCCCGTTGGCTGATTACTCGGAAGAAAGGAGAT AAAGCATTACAGATCCTGAGACGCATTGCTAAGTGCAATGGGAAATACCTCTCATCAAATTACTCAGAGATCACTGTTACAGATGAGGAA GTTAGTAATCCATCCTTTTTAGATCTGGTGAGAACTCCCCAAATGAGGAAATGCACACTTATTCTTATGTTTGCTTGGTTCACAAGCGCA GTGGTGTATCAAGGACTTGTCATGCGCCTGGGAATTATAGGGGGCAACCTCTATATAGACTTTTTCATCTCGGGCGTGGTGGAACTGCCA GGAGCTCTCTTGATCTTACTAACCATTGAGCGCCTTGGACGACGCCTCCCCTTTGCGGCAAGCAATATAGTGGCAGGGGTGGCATGCCTT GTCACTGCGTTCTTACCAGAAGGAATAGCATGGTTGAGGACCACAGTGGCTACATTGGGAAGACTAGGGATAACCATGGCCTTTGAAATT GTTTATTTGGTAAATTCAGAATTGTACCCAACAACATTACGAAATTTCGGAGTTTCGCTCTGTTCAGGTCTGTGTGATTTTGGGGGAATC ATAGCCCCATTTCTGCTCTTTCGGCTAGCAGCCGTGTGGCTAGAACTACCTCTGATCATCTTTGGTATCCTGGCATCCATCTGTGGTGGC CTTGTGATGCTTTTGCCTGAAACCAAGGGTATTGCCTTGCCAGAGACAGTGGATGATGTAGAAAAACTTGGCAGTCCACATTCCTGTAAA >In-frame_IGF2R_ENST00000356956_chr6_160431817_+_SLC22A3_ENST00000392145_chr6_160819011_+_1758nt ATGGGGGCCGCCGCCGGCCGGAGCCCCCACCTGGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTG CTCGTCGCTGCCCCGGGGTCCACGCAGGCCCAGGCCGCCCCGTTCCCCGAGCTGTGCAGTTATACATGGGAAGCTGTTGATACCAAAAAT AATGTACTTTATAAAATCAACATCTGTGGAAGTGTGGATATTGTCCAGTGCGGGCCATCAAGTGCTGTTTGTATGCACGACTTGAAGACA CGCACTTATCATTCAGTGGGTGACTCTGTTTTGAGAAGTGCAACCAGATCTCTCCTGGAATTCAACACAACAGTGAGCTGTGACCAGCAA GGCACAAATCACAGAGTCCAGAGCAGCATTGCCTTCCTGTGTGGGAAAACCCTGGGAACTCCTGAATTTGTAACTGCAACAGAATGTGTG CACTACTTTGAGTGGAGGACCACTGCAGCCTGCAAGAAAGACATATTTAAAGCAAATAAGGAGTTTGACCTTGTCTGTGTCAATGCGTGG ATGCTGGACCTCACCCAAGCCATCCTGAACCTCGGCTTCCTGACTGGAGCATTCACCTTAGGCTATGCAGCAGACAGGTATGGCAGGATC GTCATTTACTTGCTATCCTGCCTTGGTGTTGGCGTCACTGGGGTTGTGGTGGCCTTTGCACCAAACTTCCCTGTGTTTGTGATCTTCCGC TTCCTGCAAGGTGTATTTGGAAAGGGGACGTGGATGACTTGCTACGTGATTGTGACAGAAATAGTAGGTTCGAAACAAAGGAGGATTGTG GGAATCGTGATTCAAATGTTCTTTACCCTTGGAATCATAATTCTCCCTGGAATTGCCTACTTCATCCCCAACTGGCAAGGAATCCAGTTA GCCATCACGCTGCCCAGCTTTCTCTTCCTCCTTTATTACTGGGTGGTCCCTGAGTCTCCCCGTTGGCTGATTACTCGGAAGAAAGGAGAT AAAGCATTACAGATCCTGAGACGCATTGCTAAGTGCAATGGGAAATACCTCTCATCAAATTACTCAGAGATCACTGTTACAGATGAGGAA GTTAGTAATCCATCCTTTTTAGATCTGGTGAGAACTCCCCAAATGAGGAAATGCACACTTATTCTTATGTTTGCTTGGTTCACAAGCGCA GTGGTGTATCAAGGACTTGTCATGCGCCTGGGAATTATAGGGGGCAACCTCTATATAGACTTTTTCATCTCGGGCGTGGTGGAACTGCCA GGAGCTCTCTTGATCTTACTAACCATTGAGCGCCTTGGACGACGCCTCCCCTTTGCGGCAAGCAATATAGTGGCAGGGGTGGCATGCCTT GTCACTGCGTTCTTACCAGAAGCAGGAATAGCATGGTTGAGGACCACAGTGGCTACATTGGGAAGACTAGGGATAACCATGGCCTTTGAA ATTGTTTATTTGGTAAATTCAGAATTGTACCCAACAACATTACGAAATTTCGGAGTTTCGCTCTGTTCAGGTCTGTGTGATTTTGGGGGA ATCATAGCCCCATTTCTGCTCTTTCGGCTAGCAGCCGTGTGGCTAGAACTACCTCTGATCATCTTTGGTATCCTGGCATCCATCTGTGGT GGCCTTGTGATGCTTTTGCCTGAAACCAAGGGTATTGCCTTGCCAGAGACAGTGGATGATGTAGAAAAACTTGGCAGTCCACATTCCTGT |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_IGF2R_ENST00000356956_chr6_160431817_+_SLC22A3_ENST00000275300_chr6_160819011_+_3428nt CGAGCCCAGTCGAGCCGCGCTCACCTCGGGCTCCCGCTCCGTCTCCACCTCCGCCTTTGCCCTGGCGGCGCGACCCCGTCCCGGGCGCGG CCCCCAGCAGTCGCGCGCCGTTAGCCTCGCGCCCGCCGCGCAGTCCGGGCCCGGCGCGATGGGGGCCGCCGCCGGCCGGAGCCCCCACCT GGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTGCTCGTCGCTGCCCCGGGGTCCACGCAGGCCCA GGCCGCCCCGTTCCCCGAGCTGTGCAGTTATACATGGGAAGCTGTTGATACCAAAAATAATGTACTTTATAAAATCAACATCTGTGGAAG TGTGGATATTGTCCAGTGCGGGCCATCAAGTGCTGTTTGTATGCACGACTTGAAGACACGCACTTATCATTCAGTGGGTGACTCTGTTTT GAGAAGTGCAACCAGATCTCTCCTGGAATTCAACACAACAGTGAGCTGTGACCAGCAAGGCACAAATCACAGAGTCCAGAGCAGCATTGC CTTCCTGTGTGGGAAAACCCTGGGAACTCCTGAATTTGTAACTGCAACAGAATGTGTGCACTACTTTGAGTGGAGGACCACTGCAGCCTG CAAGAAAGACATATTTAAAGCAAATAAGGAGTTTGACCTTGTCTGTGTCAATGCGTGGATGCTGGACCTCACCCAAGCCATCCTGAACCT CGGCTTCCTGACTGGAGCATTCACCTTAGGCTATGCAGCAGACAGGTATGGCAGGATCGTCATTTACTTGCTATCCTGCCTTGGTGTTGG CGTCACTGGGGTTGTGGTGGCCTTTGCACCAAACTTCCCTGTGTTTGTGATCTTCCGCTTCCTGCAAGGTGTATTTGGAAAGGGGACGTG GATGACTTGCTACGTGATTGTGACAGAAATAGTAGGTTCGAAACAAAGGAGGATTGTGGGAATCGTGATTCAAATGTTCTTTACCCTTGG AATCATAATTCTCCCTGGAATTGCCTACTTCATCCCCAACTGGCAAGGAATCCAGTTAGCCATCACGCTGCCCAGCTTTCTCTTCCTCCT TTATTACTGGGTGGTCCCTGAGTCTCCCCGTTGGCTGATTACTCGGAAGAAAGGAGATAAAGCATTACAGATCCTGAGACGCATTGCTAA GTGCAATGGGAAATACCTCTCATCAAATTACTCAGAGATCACTGTTACAGATGAGGAAGTTAGTAATCCATCCTTTTTAGATCTGGTGAG AACTCCCCAAATGAGGAAATGCACACTTATTCTTATGTTTGCTTGGTTCACAAGCGCAGTGGTGTATCAAGGACTTGTCATGCGCCTGGG AATTATAGGGGGCAACCTCTATATAGACTTTTTCATCTCGGGCGTGGTGGAACTGCCAGGAGCTCTCTTGATCTTACTAACCATTGAGCG CCTTGGACGACGCCTCCCCTTTGCGGCAAGCAATATAGTGGCAGGGGTGGCATGCCTTGTCACTGCGTTCTTACCAGAAGGAATAGCATG GTTGAGGACCACAGTGGCTACATTGGGAAGACTAGGGATAACCATGGCCTTTGAAATTGTTTATTTGGTAAATTCAGAATTGTACCCAAC AACATTACGAAATTTCGGAGTTTCGCTCTGTTCAGGTCTGTGTGATTTTGGGGGAATCATAGCCCCATTTCTGCTCTTTCGGCTAGCAGC CGTGTGGCTAGAACTACCTCTGATCATCTTTGGTATCCTGGCATCCATCTGTGGTGGCCTTGTGATGCTTTTGCCTGAAACCAAGGGTAT TGCCTTGCCAGAGACAGTGGATGATGTAGAAAAACTTGGCAGTCCACATTCCTGTAAATGTGGCAGGAATAAGAAAACCCCAGTTTCCCG CTCTCACCTTTGAGGCCCCCGACAAAGACAGAAAGAAGGAGCTATCCAGGAGCTGATCCTCCTTGCAAAGCTGTGCCTTGCAGAGATGCA CGTGTGCATTTCAGCTACATCATGCCGCGCTGTTGTAATACTGTATAAAGACCTCAATCTATCCAGAGTATTTTTATATAATGTTGGATG AGTTAGGATTTGTAATGCTGTTGAAGTTTCTGGGAACACATAATATGTAGCCAGTTTAACAAAGAAGCTGTCAGGTGCACAGCCCTTCCT GGGTTTTTTTCTTGTGTTCCCTGTGGTCTCTGACCCATTAGGCTAAAGAGAGACAAGAGAAGCCCCCAACCTGATTCTCATGACAGCTCC ATCAAGAATGTGGGATGTGCCGACCAAGGATTTGAGAAAGTTGTACAGAAATGTGTTCATCAAATCTGGTCAAGGGACTAAGCTCCTAGC TGACCATTCATTCTGAAGATTGCATGGAGGATGAACATCTGGGAATCCTGTTAATGAGAAGGCTGAATCACAGGCACCTGGGCCAAAGGG TGTGAGCATTCATGTTCTCTGCTCACCTTGGTTTCCGCACACCTTCGCAATGTGAACAGGTCAGGAGTCCCTCCCGTCCACCTCCTCTGT AACAGCTGGGGTTCCAGGCATGGTTTAGGCCCTGTTCCAGCAATAAGAACCAATCTGCTGTACAATCTGAGGACTTGGCTCTGTTATTTA CAAAATGATGCTGTGGTTCTGAGATTATTTGGGACATTTTTGGCTCTCCTTTAGTGGACACCTAGAGCCACAGATTCCCTTCTTTACTAA ACAAATCCCATGGATTCTGATTTCTGGGTCTTAGGATTTTAAAAGTGAAGGGATATTTTTCTTATATTTGTGAGTTCAGTTCCGATGGTG CCCGTGGTCAAAAGCGAAAAACATGGACAATTCCTATTCATTCTTAGCACTTTGACATGTCTTGGGGAAAAGCTTACATTTTAATTTAAA AGAAAGATCAATTATATCCATGCTTAACAGGATCAGCAGGAGCTTTATAAATGACTTTACAGAGACTAATAAGGGATTTGATCTTTCTTT TTTTGTTATCGAGGCTTTTGAAATGTGGAACTTGTGTGTTCTGCTTTATATGTTATATTCAATATCTTTTCAGATGCAGTCTATATTTTA TGCTGAGTTTTAAAAATGAAATACTTTATGCAAACAGGCAAAATTGGTACCAAAGGGAAACATTAACCATGAGGAAGAGCATTTTTCTAA GGAGAACAGGTGACAATATACACATGTGCGCTAATCGTAAAATGAGCATCTTAGTCTTTAAAACACATCAGAATTGAATACGAATAATCT ATTTGTCGATGAAATAAACACAACTCTTTGAGGATTTGAGACTACATTCACCCTTTATTCACAGTCACTTGCAGTTTTGCTTTTCTCTGC ATTTCTCTGCTGTAAGATGACTGTTGCATTGTTGAATTGTATTTTGAGTGGATATTTTTGTTTGGTAACAATTAAAATTTTAAATCGTAA >In-frame_IGF2R_ENST00000356956_chr6_160431817_+_SLC22A3_ENST00000392145_chr6_160819011_+_5832nt CGAGCCCAGTCGAGCCGCGCTCACCTCGGGCTCCCGCTCCGTCTCCACCTCCGCCTTTGCCCTGGCGGCGCGACCCCGTCCCGGGCGCGG CCCCCAGCAGTCGCGCGCCGTTAGCCTCGCGCCCGCCGCGCAGTCCGGGCCCGGCGCGATGGGGGCCGCCGCCGGCCGGAGCCCCCACCT GGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTGCTCGTCGCTGCCCCGGGGTCCACGCAGGCCCA GGCCGCCCCGTTCCCCGAGCTGTGCAGTTATACATGGGAAGCTGTTGATACCAAAAATAATGTACTTTATAAAATCAACATCTGTGGAAG TGTGGATATTGTCCAGTGCGGGCCATCAAGTGCTGTTTGTATGCACGACTTGAAGACACGCACTTATCATTCAGTGGGTGACTCTGTTTT GAGAAGTGCAACCAGATCTCTCCTGGAATTCAACACAACAGTGAGCTGTGACCAGCAAGGCACAAATCACAGAGTCCAGAGCAGCATTGC CTTCCTGTGTGGGAAAACCCTGGGAACTCCTGAATTTGTAACTGCAACAGAATGTGTGCACTACTTTGAGTGGAGGACCACTGCAGCCTG CAAGAAAGACATATTTAAAGCAAATAAGGAGTTTGACCTTGTCTGTGTCAATGCGTGGATGCTGGACCTCACCCAAGCCATCCTGAACCT CGGCTTCCTGACTGGAGCATTCACCTTAGGCTATGCAGCAGACAGGTATGGCAGGATCGTCATTTACTTGCTATCCTGCCTTGGTGTTGG CGTCACTGGGGTTGTGGTGGCCTTTGCACCAAACTTCCCTGTGTTTGTGATCTTCCGCTTCCTGCAAGGTGTATTTGGAAAGGGGACGTG GATGACTTGCTACGTGATTGTGACAGAAATAGTAGGTTCGAAACAAAGGAGGATTGTGGGAATCGTGATTCAAATGTTCTTTACCCTTGG AATCATAATTCTCCCTGGAATTGCCTACTTCATCCCCAACTGGCAAGGAATCCAGTTAGCCATCACGCTGCCCAGCTTTCTCTTCCTCCT TTATTACTGGGTGGTCCCTGAGTCTCCCCGTTGGCTGATTACTCGGAAGAAAGGAGATAAAGCATTACAGATCCTGAGACGCATTGCTAA GTGCAATGGGAAATACCTCTCATCAAATTACTCAGAGATCACTGTTACAGATGAGGAAGTTAGTAATCCATCCTTTTTAGATCTGGTGAG AACTCCCCAAATGAGGAAATGCACACTTATTCTTATGTTTGCTTGGTTCACAAGCGCAGTGGTGTATCAAGGACTTGTCATGCGCCTGGG AATTATAGGGGGCAACCTCTATATAGACTTTTTCATCTCGGGCGTGGTGGAACTGCCAGGAGCTCTCTTGATCTTACTAACCATTGAGCG CCTTGGACGACGCCTCCCCTTTGCGGCAAGCAATATAGTGGCAGGGGTGGCATGCCTTGTCACTGCGTTCTTACCAGAAGCAGGAATAGC ATGGTTGAGGACCACAGTGGCTACATTGGGAAGACTAGGGATAACCATGGCCTTTGAAATTGTTTATTTGGTAAATTCAGAATTGTACCC AACAACATTACGAAATTTCGGAGTTTCGCTCTGTTCAGGTCTGTGTGATTTTGGGGGAATCATAGCCCCATTTCTGCTCTTTCGGCTAGC AGCCGTGTGGCTAGAACTACCTCTGATCATCTTTGGTATCCTGGCATCCATCTGTGGTGGCCTTGTGATGCTTTTGCCTGAAACCAAGGG TATTGCCTTGCCAGAGACAGTGGATGATGTAGAAAAACTTGGCAGTCCACATTCCTGTAAATGTGGCAGGAATAAGAAAACCCCAGTTTC CCGCTCTCACCTTTGAGGCCCCCGACAAAGACAGAAAGAAGGAGCTATCCAGGAGCTGATCCTCCTTGCAAAGCTGTGCCTTGCAGAGAT GCACGTGTGCATTTCAGCTACATCATGCCGCGCTGTTGTAATACTGTATAAAGACCTCAATCTATCCAGAGTATTTTTATATAATGTTGG ATGAGTTAGGATTTGTAATGCTGTTGAAGTTTCTGGGAACACATAATATGTAGCCAGTTTAACAAAGAAGCTGTCAGGTGCACAGCCCTT CCTGGGTTTTTTTCTTGTGTTCCCTGTGGTCTCTGACCCATTAGGCTAAAGAGAGACAAGAGAAGCCCCCAACCTGATTCTCATGACAGC TCCATCAAGAATGTGGGATGTGCCGACCAAGGATTTGAGAAAGTTGTACAGAAATGTGTTCATCAAATCTGGTCAAGGGACTAAGCTCCT AGCTGACCATTCATTCTGAAGATTGCATGGAGGATGAACATCTGGGAATCCTGTTAATGAGAAGGCTGAATCACAGGCACCTGGGCCAAA GGGTGTGAGCATTCATGTTCTCTGCTCACCTTGGTTTCCGCACACCTTCGCAATGTGAACAGGTCAGGAGTCCCTCCCGTCCACCTCCTC TGTAACAGCTGGGGTTCCAGGCATGGTTTAGGCCCTGTTCCAGCAATAAGAACCAATCTGCTGTACAATCTGAGGACTTGGCTCTGTTAT TTACAAAATGATGCTGTGGTTCTGAGATTATTTGGGACATTTTTGGCTCTCCTTTAGTGGACACCTAGAGCCACAGATTCCCTTCTTTAC TAAACAAATCCCATGGATTCTGATTTCTGGGTCTTAGGATTTTAAAAGTGAAGGGATATTTTTCTTATATTTGTGAGTTCAGTTCCGATG GTGCCCGTGGTCAAAAGCGAAAAACATGGACAATTCCTATTCATTCTTAGCACTTTGACATGTCTTGGGGAAAAGCTTACATTTTAATTT AAAAGAAAGATCAATTATATCCATGCTTAACAGGATCAGCAGGAGCTTTATAAATGACTTTACAGAGACTAATAAGGGATTTGATCTTTC TTTTTTTGTTATCGAGGCTTTTGAAATGTGGAACTTGTGTGTTCTGCTTTATATGTTATATTCAATATCTTTTCAGATGCAGTCTATATT TTATGCTGAGTTTTAAAAATGAAATACTTTATGCAAACAGGCAAAATTGGTACCAAAGGGAAACATTAACCATGAGGAAGAGCATTTTTC TAAGGAGAACAGGTGACAATATACACATGTGCGCTAATCGTAAAATGAGCATCTTAGTCTTTAAAACACATCAGAATTGAATACGAATAA TCTATTTGTCGATGAAATAAACACAACTCTTTGAGGATTTGAGACTACATTCACCCTTTATTCACAGTCACTTGCAGTTTTGCTTTTCTC TGCATTTCTCTGCTGTAAGATGACTGTTGCATTGTTGAATTGTATTTTGAGTGGATATTTTTGTTTGGTAACAATTAAAATTTTAAATCG TAAAAAATGTACATTTGCCCTTTCTCTTCCTTCTAAACATGTGTCTCTCCCACAGGTCATTCTCCTGTGACACGTGTACTGCAGAGTGTT TCAAAACCGGGCAGGCAATTAGCAATGGGAAATAAGTGGTCCACCTTCAATATTTGCTTGTTGTTCATTTACATGCTCTTGGCACCAATC CTAGACTCACGTGTGCCCCAGAATAACATTCAGACTCTCAGCTGGTCTTGTGTTACACATCCATGGACCGGTTCACTCCATCATATACAG CTCTCTGCTCCGTGTCCCCTGGGCTCAAGTCAAGCAGTCGGTGACAGATTTCATTCCCAATAACAGAATCGGTTTGCATGACTCCCCATA CATGTTGCAGCTTTGAAAACATTCATCTCAGAGTTAGGTATAAAGACATAAAAATGTGTGTCAAGCCCTCGTTAGCTGATGAGGTAAATG CATGGACAACTTCCTAGGACTTCTCGGCTCTGCCCTCTGTGACCTTGCAGCCTGCTCAGGTCTTTGTGCTCTGTTCCTTATCAAAAACAG CACAACCCCCTCAATCTGCCCATTTAAAAATTGGTGGAGTGAACAAAGAGCATGAAAATGTTGAAGACCACAACCAAAATTTACTCAAAT CAAAGTTAAGTACAGAGTTTATTTTTAACAAATGTCATAGCTATGTCACCTTACTACAGAATCCAGCAGTCAGAAAATAACACAAAAAAT GCCGAGGTTTGGCGTAGCTGGTAGCTGGGGACAGTGTCTTCGTTTGATTACTGCCAGTTATTTCCAGCATGCTAAATCCCTACCCACGTT CCAGCCTCTAGGTGAGTCAGTGCGTCACTCTGTCTCCCGTCCAATTAATTATTTCTCATCACTCCCTCAATCCAAGTAACAAACCTTGAA ACACGAACATAGACACCAGGCTTATTGGGGCGTGCACAGCCAAGACCCCAAGAAGTGACTCCTTGTAAAATGTATTTGTCCTTCTCAAAG CAAACCAGAGGCCCTCCACTGTCACCCTAAATAGAGGTAGGGAAAAATTCATGTGAGGGTTAGGCTGCCAGCCTTTTATTGTGGCATCCA TCTATTGTCCATATGTATATTTTCCCAGTAATTGAAATTGGAAAGGAACTTATGGGCATATTACTGGAGCATCTGCAGTGCTTAAGTACT TAGCAAAATCTATTCAGCGAAACCACACCACTTAGTTTCTCCCAGGGGTAAAAAAAACCCTTGTGAATCCTGCACACATCCCTTCCTGTG TTGGTGTTTCCTTTAGACTGGCCTAGCCTGGGCATCACTGTAAAGTATGTGCAGTTGGTCTCTGTCCTGTACCCTCTACCTCCTTCCCTG TCGGAAAAGTCACCACTTTAGTCCCTGGCCACCAGCACACCCCAGGAGGGTGAGTGGCCTGAGGTAGTTACGGCACTTAAAACTCCCTTG CTACCGATCTGGAACTCAAGCCCCAAGACATCCCCTTAGATGATCTGAATACGCATTCAGGGACAGATCTAGGCAGTTTCTAAACAACAC TTAGACTGGGGTCTAACGTTGACAAATCCTTCTAGAATTTGCCTCTTTGGGACTGAAGTCTAAGGGGCTGAGACCAAGAAGGGAGAGCAC AAGACTAACTTTGGTCTCTTGACCTTTTCTTACCTTGCAACTGTCAGTGCCTCCAGCCAAATGCCTAGCACAGAGCTCAGTGGATTTGAT TCTTCCATTCAGATACTCATAGCGATTGCACACTTTATTCTCAATCACAAGAAGCTGGGGCTTCCTTGAGAAGGCCAGCCCCAAAGGTAC CTGTGTTTAAAAGATGAAAGAAATGGTTGCTGAACCCAAAACATGTTTAGGAGGAAAACCAGAAGAACAGAGCAGTGGCACTGGACCTCC TGTCTGTCCGTGAGGCTGCAGAACACAAGGCAGCTCCCAATGCCGCTGGACTCTCTGACCTTGGAGAGTGTAAACATCATATATGATTCT GTGTTCCTGAGATCTGGGTTTAACGATCTGGGCTTTGTCATGGTGTTTTACGTTCGTTGTTGTTTGTGTACTTTTTGCTTTTCTTTTGAA AGTATGAAAATGATTTTTACAATGTAAAGAGAGTCTGAGAAATGCAATTGCTATTCTTTTTATATACTTTTTCAGATTTTTTATATGCTT CTTTACTACTTACATCATAATGCACAATTTTATATACTGATTTTTTCAATCAATGTATATCATGAGTTTTTAAAATAATGCTACAATCTT CATAACTAATATTTTAATGGGGAGTGACTGCTTAATTGGCATGAGGTTTCCTTTTGAGATGAGGAAAATGTTCTGAAAATATGGTGATGG |
Top |
FusionGenePPI for IGF2R_SLC22A3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
IGF2R | CREG1, PLIN3, PLAUR, USP50, ELAVL1, MYC, SIRT7, GGA2, GGA3, GGA1, CSNK2A1, FBXO6, TM9SF4, COA7, SERINC1, TIMM10B, ATXN1, FN1, CCDC8, ABCE1, EWSR1, TMEM17, TMEM216, RAB5C, XRCC5, GTSE1, CHMP4B, CDH1, PPM1H, NCDN, TRIM25 | SLC22A3 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for IGF2R_SLC22A3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | IGF2R | P11717 | DB01277 | Mecasermin | Cation-independent mannose-6-phosphate receptor | biotech | approved|investigational |
Top |
RelatedDiseases for IGF2R_SLC22A3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | IGF2R | C0024115 | Lung diseases | 2 | CTD_human |
Hgene | IGF2R | C0235833 | Congenital diaphragmatic hernia | 2 | CTD_human |
Hgene | IGF2R | C0002395 | Alzheimer's Disease | 1 | CTD_human |
Hgene | IGF2R | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | IGF2R | C0030567 | Parkinson Disease | 1 | CTD_human |
Hgene | IGF2R | C0752347 | Lewy Body Disease | 1 | CTD_human |
Hgene | IGF2R | C2239176 | Liver carcinoma | 1 | CTD_human;HPO |
Tgene | SLC22A3 | C0010246 | Coxsackievirus Infections | 1 | CTD_human |
Tgene | SLC22A3 | C0027059 | Myocarditis | 1 | CTD_human |
Tgene | SLC22A3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | SLC22A3 | C0236969 | Substance-Related Disorders | 1 | CTD_human |